<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36353127</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults.</ArticleTitle><Pagination><StartPage>1012668</StartPage><MedlinePgn>1012668</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1012668</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2022.1012668</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Autonomic dysfunction is a known complication of post-acute sequelae of SARS-CoV-2 (PASC)/long COVID, however prevalence and severity are unknown.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To assess the frequency, severity, and risk factors of autonomic dysfunction in PASC, and to determine whether severity of acute SARS-CoV-2 infection is associated with severity of autonomic dysfunction.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Cross-sectional online survey of adults with PASC recruited through long COVID support groups between October 2020 and August 2021.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">2,413 adults ages 18-64 years with PASC including patients who had a confirmed positive test for COVID-19 (test-confirmed) and participants who were diagnosed with COVID-19 based on clinical symptoms alone.</AbstractText><AbstractText Label="MAIN MEASURES" NlmCategory="UNASSIGNED">The main outcome measure was the Composite Autonomic Symptom 31 (COMPASS-31) total score, used to assess global autonomic dysfunction. Test-confirmed hospitalized vs. test-confirmed non-hospitalized participants were compared to determine if the severity of acute SARS-CoV-2 infection was associated with the severity autonomic dysfunction.</AbstractText><AbstractText Label="KEY RESULTS" NlmCategory="UNASSIGNED">Sixty-six percent of PASC patients had a COMPASS-31 score &gt;20, suggestive of moderate to severe autonomic dysfunction. COMPASS-31 scores did not differ between test-confirmed hospitalized and test-confirmed non-hospitalized participants [28.95 (15.62, 46.60) vs. 26.4 (13.75, 42.10); <i>p</i> = 0.06].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Evidence of moderate to severe autonomic dysfunction was seen in 66% of PASC patients in our study, independent of hospitalization status, suggesting that autonomic dysfunction is highly prevalent in the PASC population and independent of the severity of acute COVID-19 illness.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Larsen, Stiles, Shaik, Schneider, Muppidi, Tsui, Geng, Bonilla and Miglis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Nicholas W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stiles</LastName><ForeName>Lauren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Neurology, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dysautonomia International, East Moriches, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaik</LastName><ForeName>Ruba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Logan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Stanford Sleep Center, Department of Psychiatry and Behavioral Sciences Stanford University, Redwood City, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muppidi</LastName><ForeName>Srikanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>Cheuk To</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Chicago, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Linda N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla</LastName><ForeName>Hector</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miglis</LastName><ForeName>Mitchell G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Sleep Center, Department of Psychiatry and Behavioral Sciences Stanford University, Redwood City, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25 AI147369</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autonomic</Keyword><Keyword MajorTopicYN="N">autonomic dysfunction</Keyword><Keyword MajorTopicYN="N">dysautonomia</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>Author NL&#x2014;Grant from Dysautonomia International; Stock or stock options in Health Care Select SPDR, Ishares Biotechnology. Author LS&#x2014;Consulting fees from Eisai Pharmaceuticals (ad board, unrelated to current manuscript) and Jazz Pharmaceuticals (ad board, unrelated to current manuscript); Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Jazz Pharmaceuticals, Xywav, Xyrem and Sunosi; Payment for expert testimony from City and County of San Francisco (sleep deprivation cases); Support for attending meetings and/or travel from Jazz Pharmaceuticals (Psych Congress 2021, poster presentation); Leadership or fiduciary role in other board, society, committee or advocacy group from Graduate Education Subcommittee Chair (AAN, unpaid), Graduate Education Subcommittee Chair (AAN, unpaid), Editorial Board (Practical Neurology, unpaid); Stock or stock options in Alphabet. Author SM&#x2014;Grants or contracts from the Myasthenia Gravis Foundation of America; Consulting fees from Argenx, Alexion and UCB pharma (consultation and advisory board meetings). Author LG&#x2014;Consulting fees from United Health Group. Author MM&#x2014;Royalties from Elsvier Inc.; Consulting fees from 2nd MD, Infinite MD and Guidepoint LLC; Payments for CME lectures from MED-IQ; Payment for expert testimony from Van Cott Talamante (expert witness); Medical Advisory Board of Dysautonomia International (unpaid), and MSA Coalitionn (unpaid). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>2</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36353127</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster&#x2014;long-haul Covid. N Engl J Med. (2021) 385:577&#x2013;9. 10.1056/NEJMp2109285</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan M V, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, Stiles LE, Miglis MG. Preparing for the long-haul: autonomic complications of COVID-19. Auton Neurosci. (2021) 235:102841. 10.1016/j.autneu.2021.102841</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102841</ArticleId><ArticleId IdType="pmc">PMC8254396</ArticleId><ArticleId IdType="pubmed">34265539</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClin Med. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W, COMPASS. 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. (2012) 87:1196&#x2013;201. 10.1016/j.mayocp.2012.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Zoller T, Steinbeis F, et al. . Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany&#x2014;a first analysis of a prospective observational study. medRxiv. (2021). 10.1101/2021.02.06.21249256</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.06.21249256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res. (2012) 22:79&#x2013;90. 10.1007/s10286-011-0146-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-011-0146-2</ArticleId><ArticleId IdType="pubmed">22045363</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, Larocca NG, Muir Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. (1989) 46:1121&#x2013;3. 10.1001/archneur.1989.00520460115022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. (1991) 14:540&#x2013;5. 10.1093/sleep/14.6.540</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/14.6.540</ArticleId><ArticleId IdType="pubmed">1798888</ArticleId></ArticleIdList></Reference><Reference><Citation>Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. (1997) 48:332&#x2013;8. 10.1212/WNL.48.2.332</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.2.332</ArticleId><ArticleId IdType="pubmed">9040716</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. (2006) 166:1092&#x2013;7. 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>-Item Short Form Survey (SF-36) | RAND. Available online at: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html [accessed on December 20, 2021).</Citation></Reference><Reference><Citation>Guido van Rossum . Python tutorial, Technical Report CS-R9526. Amsterdam: Centrum voor Wiskunde en Informatica (CWI) (1995).</Citation></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, Rodr&#xed;guez Y, Roa G, Lozano M, et al. . Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. (2021) 20:102947. 10.1016/j.autrev.2021.102947</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March-June 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:993&#x2013;8. 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. . Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. (2020) 81:e4&#x2013;6. 10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold AC, Ng J, Raj SR. Postural tachycardia syndrome&#x2014;Diagnosis, physiology, and prognosis. Auton Neurosci. (2018) 215:3&#x2013;11. 10.1016/j.autneu.2018.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.005</ArticleId><ArticleId IdType="pmc">PMC6113123</ArticleId><ArticleId IdType="pubmed">29523389</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. (2009) 20:352&#x2013;8. 10.1111/j.1540-8167.2008.01407.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2008.01407.x</ArticleId><ArticleId IdType="pmc">PMC3904426</ArticleId><ArticleId IdType="pubmed">19207771</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon RS, Grubb BP, Olshansky B, Shen WK, Calkins H, Brignole M, et al. . 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. (2015) 12:e41&#x2013;63. 10.1016/j.hrthm.2015.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.03.029</ArticleId><ArticleId IdType="pmc">PMC5267948</ArticleId><ArticleId IdType="pubmed">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension. (2006) 48:787&#x2013;96. 10.1161/01.HYP.0000242642.42177.49</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000242642.42177.49</ArticleId><ArticleId IdType="pubmed">17000932</ArticleId></ArticleIdList></Reference><Reference><Citation>Narkiewicz K, Van De Borne PJH, Hausberg M, Cooley RL, Winniford MD, Davison DE, et al. . Cigarette smoking increases sympathetic outflow in humans. Circulation. (1998) 98:528&#x2013;34. 10.1161/01.CIR.98.6.528</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.98.6.528</ArticleId><ArticleId IdType="pubmed">9714109</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderminden J, Esala JJ. Beyond symptoms: race and gender predict anxiety disorder diagnosis. Soc Ment Health. (2019) 9:111&#x2013;25. 10.1177/2156869318811435</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2156869318811435</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi G. Sympathetic overdrive in hypertension: clinical and therapeutic relevance. J Cardiol Pract. (2015) 13:24.</Citation></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Jabal KA, et al. . Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021. medRxiv. (2022). 10.1101/2022.01.05.22268800</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.05.22268800</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S, et al. . case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. (2020) 30:449&#x2013;51. 10.1007/s10286-020-00727-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00727-9</ArticleId><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K, Jamal S, Kichloo A, Grubb B. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Card Rhythm Manag. (2020) 11:4302&#x2013;4. 10.19102/icrm.2020.111102</Citation><ArticleIdList><ArticleId IdType="doi">10.19102/icrm.2020.111102</ArticleId><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x2018;long COVID': rationale, physiology and management strategies. Clin Med (Lond). (2021) 21:e63&#x2013;7. 10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. . Long-haul post&#x2013;COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. (2021) 3:573&#x2013;80. 10.1016/j.jaccas.2021.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, et al. . Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol. (2021) 28:3348&#x2013;59. 10.1111/ene.14803</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Ruiz-Ruig&#xf3;mez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, Gonz&#xe1;lez-Cuadrado C, et al. . A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomedicines. (2021) 9:1540. 10.3390/biomedicines9111540</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111540</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20:172. 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>